Answers are grounded in this paper and cite their sources.
The authors review the potential benefits and unintended consequences of the broad sharing of participant-level data from clinical trials. Several options for governance structures that could be implemented to provide expanded access to clinical trial data are discussed.
No takes yet. Share an insight, caveat, or question.
Mello et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: